Europe

COVID-19 vaccine licenses: EU countries divided over lifting intellectual property rights

Several EU leaders approved the US call to remove patent protections on COVID-19 vaccines to help developing countries obtain shots. But the proposal faced resistance, notably from Germany.

The EU is “ready to discuss” lifting intellectual property protections on COVID-19 vaccines, Ursula von der Leyen said on Thursday.

More than 100 nations have been struggling for the IP rights on coronavirus vaccines and treatments to be waived in order to speed up the production of jabs.

The US on Wednesday said it was supporting the ideas for what is essentially a patent waiver between World Trade Organization (WTO) talks on the issue.

European Commission president von der Leyen said the bloc would discuss “any plan that would take the crisis efficiently and pragmatically”.

“I completely support this break up of the intellectual property,” French President Emmanuel Macron said.

However, like many pharmaceutical companies, Macron said that a waiver would not solve access to vaccines. He said manufacturers in places like Africa are not now equipped to make COVID-19 vaccines, so contributions of shots from more affluent countries should be given preference instead.

Italian Foreign Minister Luigi Di Maio wrote on Facebook that the US announcement was “a significant sign” and that the world needs “free access” to vaccine patents. But Italian Premier Mario Draghi was more circumspect.

‘Source of innovation’
Meanwhile, German Chancellor Angela Merkel’s office spoke out against it, saying: “The protection of the intellectual property is a source of change and must remain so in the future.”

A Merkel spokeswoman, speaking on common anonymity, said Germany is focused instead on increasing vaccine manufacturers’ production capacity.

During WTO talks, the US Trade Representative Katherine Tai said the Biden administration “believes heavily in mental property protections, but in service of doing this pandemic, encourages the abandonment of those protections for COVID-19 vaccines”.

The temporary restriction on IP rights would allow more companies to manufacture the vaccines.

ccenews

Recent Posts

Swiss Glaciers Lose More Than 5% of Ice After Extreme Summer Heatwaves

More than 5% of Switzerland’s remaining glacier ice disappeared during the past year, according to… Read More

2 days ago

Verstappen Leads Malaysian Grand Prix Practice as Formula 1 Returns to Sepang

Max Verstappen topped the opening Malaysian Grand Prix practice session at Sepang, beating George Russell… Read More

2 days ago

Russian Strikes Force Ukraine Steel Giant to Shut Down, Deepening Economic Strain

Zaporizhstal, a major employer in Zaporizhzhia, has shut indefinitely after four Russian attack waves destroyed… Read More

3 days ago

France Moves to End One-In, One-Out Migration Deal With UK

France is set to end its one-in, one-out migration agreement with Britain after Paris and… Read More

3 days ago

Esteban Ocon Fights to Keep Formula 1 Career Alive After Haas Exit

Esteban Ocon is facing a difficult fight to remain in Formula 1 after Haas announced… Read More

3 days ago

French Student Protests Spread Nationwide as Arrests and Injuries Rise

French students are blocking schools across the country over overcrowded classrooms, teacher shortages and poor… Read More

3 days ago

This website uses cookies.